Wave Life Sciences Stock Price, News & Analysis (NASDAQ:WVE)

$50.75 +0.15 (+0.30 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$50.75
Today's Range$49.85 - $51.45
52-Week Range$15.15 - $55.95
Volume122,276 shs
Average Volume174,029 shs
Market Capitalization$1.41 billion
P/E Ratio-14.34
Dividend YieldN/A
Beta0.93

About Wave Life Sciences (NASDAQ:WVE)

Wave Life Sciences logoWAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:WVE
CUSIPN/A
Phone65-6236-3388

Debt

Debt-to-Equity Ratio0.01%
Current Ratio11.50%
Quick Ratio11.50%

Price-To-Earnings

Trailing P/E Ratio-14.3361581920904
Forward P/E Ratio-13.50
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.49 million
Price / Sales950.29
Cash FlowN/A
Price / CashN/A
Book Value$5.74 per share
Price / Book8.84

Profitability

Trailing EPS($3.54)
Net Income$-55,400,000.00
Net Margins-3,338.68%
Return on Equity-59.52%
Return on Assets-48.48%

Miscellaneous

Employees96
Outstanding Shares27,900,000

Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd (NASDAQ:WVE) posted its earnings results on Thursday, November, 9th. The company reported ($0.94) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.97) by $0.03. The business had revenue of $0.68 million for the quarter, compared to analysts' expectations of $0.77 million. Wave Life Sciences had a negative net margin of 3,338.68% and a negative return on equity of 59.52%. View Wave Life Sciences' Earnings History.

When will Wave Life Sciences make its next earnings announcement?

Wave Life Sciences is scheduled to release their next quarterly earnings announcement on Thursday, March, 15th 2018. View Earnings Estimates for Wave Life Sciences.

Where is Wave Life Sciences' stock going? Where will Wave Life Sciences' stock price be in 2018?

5 analysts have issued 1 year target prices for Wave Life Sciences' stock. Their forecasts range from $34.00 to $64.00. On average, they anticipate Wave Life Sciences' share price to reach $44.50 in the next year. View Analyst Ratings for Wave Life Sciences.

Who are some of Wave Life Sciences' key competitors?

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the folowing people:

  • Gregory L. Verdine Ph.D., Independent Chairman of the Board (Age 58)
  • Paul B. Bolno M.D., President, Chief Executive Officer, Director (Age 43)
  • Keith C. Regnante, Chief Financial Officer (Age 47)
  • Christopher Francis Ph.D., Senior Vice President, Corporate Development & Portfolio Management (Age 39)
  • Chandra Vargeese Ph.D., Senior Vice President, Head of Drug Discovery (Age 56)
  • Michael Panzara M.D., Franchise Lead, Neurology (Age 50)
  • Ken Takanashi, Director (Age 53)
  • Christian O. Henry, Additional Independent Director (Age 49)
  • Peter Kolchinsky Ph.D., Independent Director (Age 40)
  • Koji Miura, Independent Director (Age 68)

Who owns Wave Life Sciences stock?

Wave Life Sciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include Redmile Group LLC (7.95%), BlackRock Inc. (3.36%), Perceptive Advisors LLC (2.39%), ArrowMark Colorado Holdings LLC (1.50%), Bridger Management LLC (1.22%) and Artal Group S.A. (0.33%). Company insiders that own Wave Life Sciences stock include Chandra Vargeese, Chris Francis, Gregory L Verdine, Keith Regnante, Masaharu Tanaka, Michael A Panzara and Ra Capital Management, Llc. View Institutional Ownership Trends for Wave Life Sciences.

Who sold Wave Life Sciences stock? Who is selling Wave Life Sciences stock?

Wave Life Sciences' stock was sold by a variety of institutional investors in the last quarter, including Redmile Group LLC, ArrowMark Colorado Holdings LLC, Emory University, Deutsche Bank AG, Iguana Healthcare Management LLC, Rhumbline Advisers, Wells Fargo & Company MN and TIAA CREF Investment Management LLC. Company insiders that have sold Wave Life Sciences company stock in the last year include Chandra Vargeese, Chris Francis, Keith Regnante, Masaharu Tanaka and Michael A Panzara. View Insider Buying and Selling for Wave Life Sciences.

Who bought Wave Life Sciences stock? Who is buying Wave Life Sciences stock?

Wave Life Sciences' stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Artal Group S.A., Bailard Inc., Bridger Management LLC, Spark Investment Management LLC, Two Sigma Investments LP, Perceptive Advisors LLC and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Wave Life Sciences.

How do I buy Wave Life Sciences stock?

Shares of Wave Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of Wave Life Sciences stock can currently be purchased for approximately $50.75.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $1.41 billion and generates $1.49 million in revenue each year. The company earns $-55,400,000.00 in net income (profit) each year or ($3.54) on an earnings per share basis. Wave Life Sciences employs 96 workers across the globe.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 8 CROSS STREET, SINGAPORE U0, 048424. The company can be reached via phone at 65-6236-3388 or via email at [email protected]


MarketBeat Community Rating for Wave Life Sciences (WVE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  139 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  238
MarketBeat's community ratings are surveys of what our community members think about Wave Life Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Wave Life Sciences (NASDAQ:WVE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.50$41.60$41.60$40.00
Price Target Upside: 14.59% downside68.08% upside68.08% upside139.52% upside

Wave Life Sciences (NASDAQ:WVE) Consensus Price Target History

Price Target History for Wave Life Sciences (NASDAQ:WVE)

Wave Life Sciences (NASDAQ:WVE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/21/2018Leerink SwannBoost Price TargetOutperform -> Outperform$53.00 -> $64.00MediumView Rating Details
2/20/2018MizuhoSet Price TargetBuy$34.00MediumView Rating Details
8/10/2017Jefferies GroupReiterated RatingBuy$42.00 -> $40.00LowView Rating Details
6/9/2017JMP SecuritiesReiterated RatingOutperform$40.00LowView Rating Details
3/27/2017HC WainwrightReiterated RatingBuyHighView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Wave Life Sciences (NASDAQ:WVE) Earnings History and Estimates Chart

Earnings by Quarter for Wave Life Sciences (NASDAQ:WVE)

Wave Life Sciences (NASDAQ WVE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/15/2018        
11/9/2017Q3 2017($0.97)($0.94)$0.77 million$0.68 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.78)($0.92)$0.73 million$0.68 millionViewN/AView Earnings Details
5/10/20173/31/2017($0.77)($0.89)$0.80 million$0.68 millionViewN/AView Earnings Details
3/16/2017Q4 2016($0.80)($0.79)$0.56 million$0.68 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.53)($0.75)$0.50 million$0.39 millionViewN/AView Earnings Details
8/15/2016Q2($0.37)($0.51)$0.42 millionViewN/AView Earnings Details
5/16/2016Q1($0.37)($0.36)ViewN/AView Earnings Details
3/30/2016Q4($0.28)($0.47)ViewN/AView Earnings Details
12/17/2015Q3 2015($0.29)($0.54)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Wave Life Sciences (NASDAQ:WVE) Earnings Estimates

2018 EPS Consensus Estimate: ($2.38)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.97)($0.11)($0.54)
Q2 20182($0.99)($0.15)($0.57)
Q3 20182($1.02)($0.20)($0.61)
Q4 20182($1.05)($0.27)($0.66)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Wave Life Sciences (NASDAQ:WVE)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Wave Life Sciences (NASDAQ WVE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 53.00%
Institutional Ownership Percentage: 74.27%
Insider Trades by Quarter for Wave Life Sciences (NASDAQ:WVE)
Institutional Ownership by Quarter for Wave Life Sciences (NASDAQ:WVE)

Wave Life Sciences (NASDAQ WVE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Chris FrancisInsiderSell21,639$55.40$1,198,800.60View SEC Filing  
2/16/2018Keith RegnanteCFOSell316$51.85$16,384.60View SEC Filing  
2/16/2018Michael A PanzaraInsiderSell511$52.10$26,623.10View SEC Filing  
1/23/2018Chandra VargeeseInsiderSell2,000$40.00$80,000.00View SEC Filing  
11/22/2017Chandra VargeeseInsiderSell1,500$35.00$52,500.00View SEC Filing  
11/14/2017Ra Capital Management, LlcDirectorBuy423,398$23.34$9,882,109.32View SEC Filing  
9/18/2017Masaharu TanakaDirectorSell20,747$24.21$502,284.87View SEC Filing  
7/12/2017Michael A PanzaraInsiderSell7,414$16.67$123,591.3815,336View SEC Filing  
3/29/2017Masaharu TanakaDirectorSell433,825$24.91$10,806,580.75View SEC Filing  
6/15/2016Gregory L VerdineDirectorSell52,000$16.70$868,400.00150,079View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Wave Life Sciences (NASDAQ WVE) News Headlines

Source:
DateHeadline
Research Analysts Offer Predictions for Wave Life Sciences Ltds Q1 2018 Earnings (WVE)Research Analysts Offer Predictions for Wave Life Sciences Ltd's Q1 2018 Earnings (WVE)
www.americanbankingnews.com - February 23 at 8:24 AM
Q1 2018 EPS Estimates for Wave Life Sciences Ltd Increased by Leerink Swann (WVE)Q1 2018 EPS Estimates for Wave Life Sciences Ltd Increased by Leerink Swann (WVE)
www.americanbankingnews.com - February 23 at 8:24 AM
Wave Life Sciences teams up with Takeda to develop CNS treatmentsWave Life Sciences teams up with Takeda to develop CNS treatments
seekingalpha.com - February 22 at 4:19 PM
Wave Life Sciences Ltd (WVE) Forecasted to Post FY2022 Earnings of ($3.54) Per ShareWave Life Sciences Ltd (WVE) Forecasted to Post FY2022 Earnings of ($3.54) Per Share
www.americanbankingnews.com - February 22 at 4:14 PM
Wave Life Sciences Ltd (WVE) CFO Keith Regnante Sells 316 SharesWave Life Sciences Ltd (WVE) CFO Keith Regnante Sells 316 Shares
www.americanbankingnews.com - February 21 at 9:38 PM
Insider Selling: Wave Life Sciences Ltd (WVE) Insider Sells 511 Shares of StockInsider Selling: Wave Life Sciences Ltd (WVE) Insider Sells 511 Shares of Stock
www.americanbankingnews.com - February 21 at 9:38 PM
Chris Francis Sells 21,639 Shares of Wave Life Sciences Ltd (WVE) StockChris Francis Sells 21,639 Shares of Wave Life Sciences Ltd (WVE) Stock
www.americanbankingnews.com - February 21 at 9:06 PM
Wave Life Sciences (WVE) Rating Increased to Strong-Buy at BidaskClubWave Life Sciences (WVE) Rating Increased to Strong-Buy at BidaskClub
www.americanbankingnews.com - February 21 at 7:10 PM
Wave Life Sciences Ltd (WVE) Given Average Rating of "Buy" by BrokeragesWave Life Sciences Ltd (WVE) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 21 at 5:32 PM
Leerink Swann Raises Wave Life Sciences (WVE) Price Target to $64.00Leerink Swann Raises Wave Life Sciences (WVE) Price Target to $64.00
www.americanbankingnews.com - February 21 at 11:10 AM
Mizuho Reaffirms "Buy" Rating for Wave Life Sciences (WVE)Mizuho Reaffirms "Buy" Rating for Wave Life Sciences (WVE)
www.americanbankingnews.com - February 20 at 8:26 PM
Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System DisordersWave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders
finance.yahoo.com - February 20 at 9:22 AM
Wave Life Sciences (WVE) Upgraded at BidaskClubWave Life Sciences (WVE) Upgraded at BidaskClub
www.americanbankingnews.com - February 19 at 1:02 PM
Zacks: Brokerages Expect Wave Life Sciences Ltd (WVE) Will Announce Quarterly Sales of $630,000.00Zacks: Brokerages Expect Wave Life Sciences Ltd (WVE) Will Announce Quarterly Sales of $630,000.00
www.americanbankingnews.com - February 16 at 11:06 AM
WVE Crosses Above Average Analyst TargetWVE Crosses Above Average Analyst Target
www.nasdaq.com - February 16 at 9:24 AM
Zacks: Brokerages Anticipate Wave Life Sciences Ltd (WVE) Will Announce Earnings of -$1.00 Per ShareZacks: Brokerages Anticipate Wave Life Sciences Ltd (WVE) Will Announce Earnings of -$1.00 Per Share
www.americanbankingnews.com - February 14 at 3:16 AM
Wave Life Sciences to Participate in Leerink Partners 7th Annual Global Healthcare ConferenceWave Life Sciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 8 at 3:21 PM
Wave Life Sciences (WVE) Cut to Hold at BidaskClubWave Life Sciences (WVE) Cut to Hold at BidaskClub
www.americanbankingnews.com - February 1 at 6:52 AM
Wave Life Sciences Ltd (WVE) Expected to Announce Quarterly Sales of $630,000.00Wave Life Sciences Ltd (WVE) Expected to Announce Quarterly Sales of $630,000.00
www.americanbankingnews.com - January 30 at 8:10 AM
Wave Life Sciences Ltd (WVE) Given Consensus Rating of "Buy" by AnalystsWave Life Sciences Ltd (WVE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - January 27 at 5:34 PM
BidaskClub Upgrades Wave Life Sciences (WVE) to "Buy"BidaskClub Upgrades Wave Life Sciences (WVE) to "Buy"
www.americanbankingnews.com - January 27 at 1:12 PM
Form 4 Wave Life Sciences Ltd. For: Jan 23 Filed by: Vargeese ChandraForm 4 Wave Life Sciences Ltd. For: Jan 23 Filed by: Vargeese Chandra
www.streetinsider.com - January 26 at 5:58 AM
Insider Selling: Wave Life Sciences Ltd (WVE) Insider Sells 2,000 Shares of StockInsider Selling: Wave Life Sciences Ltd (WVE) Insider Sells 2,000 Shares of Stock
www.americanbankingnews.com - January 26 at 12:20 AM
Zacks Investment Research Lowers Wave Life Sciences (WVE) to SellZacks Investment Research Lowers Wave Life Sciences (WVE) to Sell
www.americanbankingnews.com - January 13 at 2:42 PM
Zacks: Analysts Anticipate Wave Life Sciences Ltd (WVE) Will Post Quarterly Sales of $630,000.00Zacks: Analysts Anticipate Wave Life Sciences Ltd (WVE) Will Post Quarterly Sales of $630,000.00
www.americanbankingnews.com - January 13 at 2:00 PM
Wave Life Sciences (WVE) Upgraded to "C-" at TheStreetWave Life Sciences (WVE) Upgraded to "C-" at TheStreet
www.americanbankingnews.com - January 11 at 9:40 AM
GTX (GTXI) vs. Wave Life Sciences (WVE) Head-To-Head ContrastGTX (GTXI) vs. Wave Life Sciences (WVE) Head-To-Head Contrast
www.americanbankingnews.com - January 4 at 5:02 PM
Wave Life Sciences Ltd (WVE) Given Average Rating of "Buy" by AnalystsWave Life Sciences Ltd (WVE) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 2 at 5:40 PM
ETFs with exposure to Wave Life Sciences Ltd. : December 26, 2017ETFs with exposure to Wave Life Sciences Ltd. : December 26, 2017
finance.yahoo.com - December 26 at 8:36 PM
Wave Life Sciences Ltd. :WVE-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017Wave Life Sciences Ltd. :WVE-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 5:48 PM
Wave Life Sciences Ltd (WVE) Receives Consensus Recommendation of "Buy" from AnalystsWave Life Sciences Ltd (WVE) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 8 at 7:44 PM
BidaskClub Upgrades WAVE Life Sciences (WVE) to "Strong-Buy"BidaskClub Upgrades WAVE Life Sciences (WVE) to "Strong-Buy"
www.americanbankingnews.com - December 2 at 11:14 AM
Head to Head Review: Curis (CRIS) and WAVE Life Sciences (WVE)Head to Head Review: Curis (CRIS) and WAVE Life Sciences (WVE)
www.americanbankingnews.com - November 29 at 7:30 PM
WAVE Life Sciences Ltd. (WVE) Upgraded by BidaskClub to "Hold"WAVE Life Sciences Ltd. (WVE) Upgraded by BidaskClub to "Hold"
www.americanbankingnews.com - November 26 at 12:52 AM
Chandra Vargeese Sells 1,500 Shares of WAVE Life Sciences Ltd. (WVE) StockChandra Vargeese Sells 1,500 Shares of WAVE Life Sciences Ltd. (WVE) Stock
www.americanbankingnews.com - November 23 at 1:24 PM
 Analysts Expect WAVE Life Sciences Ltd. (WVE) Will Post Quarterly Sales of $640,000.00 Analysts Expect WAVE Life Sciences Ltd. (WVE) Will Post Quarterly Sales of $640,000.00
www.americanbankingnews.com - November 22 at 2:10 PM
Zacks: Analysts Anticipate WAVE Life Sciences Ltd. (WVE) to Post -$1.00 Earnings Per ShareZacks: Analysts Anticipate WAVE Life Sciences Ltd. (WVE) to Post -$1.00 Earnings Per Share
www.americanbankingnews.com - November 20 at 3:06 AM
WAVE Life Sciences Ltd. to Post FY2018 Earnings of ($4.52) Per Share, Leerink Swann Forecasts (WVE)WAVE Life Sciences Ltd. to Post FY2018 Earnings of ($4.52) Per Share, Leerink Swann Forecasts (WVE)
www.americanbankingnews.com - November 18 at 8:46 AM
Ra Capital Management, Llc Purchases 423,398 Shares of WAVE Life Sciences Ltd. (WVE) StockRa Capital Management, Llc Purchases 423,398 Shares of WAVE Life Sciences Ltd. (WVE) Stock
www.americanbankingnews.com - November 15 at 7:31 PM
WAVE Life Sciences Ltd. (WVE) Earns "Outperform" Rating from Leerink SwannWAVE Life Sciences Ltd. (WVE) Earns "Outperform" Rating from Leerink Swann
www.americanbankingnews.com - November 15 at 11:42 AM
WAVE Life Sciences Ltd. (WVE) Given Average Recommendation of "Hold" by AnalystsWAVE Life Sciences Ltd. (WVE) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 13 at 7:56 PM
WAVE Life Sciences Ltd. (WVE) Announces  Earnings ResultsWAVE Life Sciences Ltd. (WVE) Announces Earnings Results
www.americanbankingnews.com - November 10 at 2:34 PM
Wave Life Sciences Ltd. breached its 50 day moving average in a Bearish Manner : WVE-US : November 8, 2017Wave Life Sciences Ltd. breached its 50 day moving average in a Bearish Manner : WVE-US : November 8, 2017
finance.yahoo.com - November 9 at 10:13 AM
Wave Life Sciences Reports Third Quarter 2017 Financial Results and Provides Business UpdateWave Life Sciences Reports Third Quarter 2017 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 10:13 AM
Wave Life Sciences reports 3Q lossWave Life Sciences reports 3Q loss
finance.yahoo.com - November 9 at 10:13 AM
WAVE Life Sciences Ltd. (WVE) Expected to Announce Quarterly Sales of $770,000.00WAVE Life Sciences Ltd. (WVE) Expected to Announce Quarterly Sales of $770,000.00
www.americanbankingnews.com - November 1 at 6:44 AM
Wave Life Sciences Ltd. – Value Analysis (NASDAQ:WVE) : October 30, 2017Wave Life Sciences Ltd. – Value Analysis (NASDAQ:WVE) : October 30, 2017
finance.yahoo.com - October 31 at 12:26 PM
Zacks: Brokerages Expect WAVE Life Sciences Ltd. (WVE) Will Announce Earnings of -$0.91 Per ShareZacks: Brokerages Expect WAVE Life Sciences Ltd. (WVE) Will Announce Earnings of -$0.91 Per Share
www.americanbankingnews.com - October 30 at 3:22 PM
WAVE Life Sciences Ltd. (WVE) Cut to "Sell" at BidaskClubWAVE Life Sciences Ltd. (WVE) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - October 28 at 7:02 AM
Wave Life Sciences Ltd. breached its 50 day moving average in a Bearish Manner : WVE-US : October 27, 2017Wave Life Sciences Ltd. breached its 50 day moving average in a Bearish Manner : WVE-US : October 27, 2017
finance.yahoo.com - October 27 at 4:58 PM

SEC Filings

Wave Life Sciences (NASDAQ:WVE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Wave Life Sciences (NASDAQ:WVE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Wave Life Sciences (NASDAQ WVE) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.